surgery for t2dm in bmis < 35 the center of excelence for the surgical treatment of obesity and...
TRANSCRIPT
![Page 1: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/1.jpg)
Surgery for T2DM in BMIs < 35
• The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders
Hospital Oswaldo Cruz, São Paulo, Brasil
Ricardo Cohen MD FACS
![Page 2: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/2.jpg)
Type 2 Diabetes: An operable Intestinal Type 2 Diabetes: An operable Intestinal Disease?Disease?
• Why operate? Evidences in the obese population:
• Dr Pories already showed everything!
• Evidences of resolution without direct relation to weight loss in some bariatric operations (Laferrere,2008;Lee,2008;Patou 2008)
Previous speakers did the job!!
![Page 3: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/3.jpg)
Surgery over the GI tract can Surgery over the GI tract can improve T2DM controlimprove T2DM control
• 10 to 15% of T2DM are normal weight 10 to 15% of T2DM are normal weight (Mokad, in JAMA,2000)(Mokad, in JAMA,2000)
• 70% of morbidly obese patients have NO T2DM!!70% of morbidly obese patients have NO T2DM!!
If it seems that there is a surgical induced antidiabetic If it seems that there is a surgical induced antidiabetic effect, and most diabetics in the world are effect, and most diabetics in the world are NOTNOT morbidly morbidly obese, most of them areobese, most of them are NOT NOT under control, why not offer under control, why not offer this option to some selected patients???this option to some selected patients???
If it seems that there is a surgical induced antidiabetic If it seems that there is a surgical induced antidiabetic effect, and most diabetics in the world are effect, and most diabetics in the world are NOTNOT morbidly morbidly obese, most of them areobese, most of them are NOT NOT under control, why not offer under control, why not offer this option to some selected patients???this option to some selected patients???
45 % with BMI BELOW 3045 % with BMI BELOW 30
![Page 4: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/4.jpg)
Options
AGB
RYGB BPD
![Page 5: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/5.jpg)
13 |
Glycemia as an Endpoint
Year Author N Level TherapyControl Outcome
2008 Dixon J 60 ALAGB (BMI 30-40
kg/m2)
Medical management
72% Resolution of Type 2 DM
2006 O’Brien PE 79 ALAGB (BMI 30-34
kg/m2)
Medical management
Reduction in metabolic syndrome 93%- surgery vs.
46%- medical management
2008 Lee WJ 158 C RYGBP < 35 kg/m2
RYGBP >35 kg/m2
76.5% success in BMI<35 kg/m2; 88.9% success in BMI 35–45 kg/m2,
2006 Cohen R 37 C RYGBP < 35 kg/m2
97% Resolution of Type 2 DM
2009 Chiellini C 5 C BPD < 35 kg/m2
Low energy diet
100% Resolution of Type 2 DM; no improvement in diet group
![Page 6: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/6.jpg)
•April 2002- Feb 2008
•127 patients
•28 - 63 years-old ( mean of 44)
•98 women
WE HAVE STARTED WITH THE LRYGB
![Page 7: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/7.jpg)
BMI 30-31 31.1-32
32.1-33
33.1-34
34.1-34.9
Pts 24(19%) 33(26%) 39(31.5%) 19(15%) 12(8.5%)
T2DM 13 10 20 13 10
127 Patients
66 T2DM(52%)
Effect of RYGB in patients with BMI < 35 kg/m2
![Page 8: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/8.jpg)
•Uncontrolled T2DM after 12 mo of agressive medical and behavioral treatment
•History of T2DM from 2 to 20 years
•Fasting C peptide over 1 that increases after a meal challenge
LRYGB was indicated when:
![Page 9: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/9.jpg)
RYGB, BMI 30-35Cohen at al.
![Page 10: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/10.jpg)
RYGB, BMI 30-35Cohen at al.
A1c
![Page 11: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/11.jpg)
RYGB, BMI 30-35Cohen at al.
EWL, 72 months follow up
![Page 12: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/12.jpg)
RYGB, BMI 30-35Cohen at al.
![Page 13: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/13.jpg)
RYGB, BMI 30-35Cohen at al.
•No mortality
•No leaks
•1 reoperation due to intestinal obstruction
•4.5% of minor complications ( port site hematomas, vomiting)
![Page 14: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/14.jpg)
Duodenal-Jejunal Bypass
with sleeve gastrectom
y
Ileal interposition Sleeve gastrectomyNovel procedures
![Page 15: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/15.jpg)
T2DM & THE METABOLIC EFFECTS OF BARIATRIC SURGERYT2DM & THE METABOLIC EFFECTS OF BARIATRIC SURGERY
Novel Surgical OptionsNovel Surgical Options
• Ileal Interposition +/- Sleeve GastrectomyIleal Interposition +/- Sleeve Gastrectomy• Physiologic Basis = Enteroinsular AxisPhysiologic Basis = Enteroinsular Axis
• HighlightsHighlights• Complex MIS procedureComplex MIS procedure
• 3 GI anastomosis3 GI anastomosis
• Scant worldwide experienceScant worldwide experience
![Page 16: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/16.jpg)
T2DM & THE METABOLIC EFFECTS OF BARIATRIC SURGERYT2DM & THE METABOLIC EFFECTS OF BARIATRIC SURGERY
Novel Surgical OptionsNovel Surgical Options• “ “First in Man” Ileal interposition & Sleeve GastrectomyFirst in Man” Ileal interposition & Sleeve Gastrectomy
• 19 patients19 patients• Mean 37 years oldMean 37 years old• Mean BMI 40 (range 35-44)Mean BMI 40 (range 35-44)
• Select co-morbiditySelect co-morbidity– n=5 T2DM n=5 T2DM - At 3 weeks, 5/5 T2DM patients off meds with normal FPG- At 3 weeks, 5/5 T2DM patients off meds with normal FPG– n=8 HTNn=8 HTN– n=2 OSAn=2 OSA– n=11 hyperlipidemian=11 hyperlipidemia
A dePaula et.al. SOARD, 2006
![Page 17: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/17.jpg)
Ileal interposition- De Paula, 2008
• Conclusions: Laparoscopic II-SG and II-DSG seem to be promising procedures for the control of the metabolic syndrome and type 2 diabetes mellitus. Excluding the duodenum may improve results. A longer follow-up period is needed.
Surg EndoscSurg Endosc
![Page 18: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/18.jpg)
De Paula II/SGII
Adding a duodenal exclusion improves results (SOARD,2010)
RCT II +Duodenal Exclusion x Ileal interposition WITHOUT Duodenal
Exclusion
![Page 19: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/19.jpg)
Ileal Interposition- De Paula
• It’s effective, although complex a procedure :
• ~ 10% of pts with BMI 20-22 were operated(some LADA included, probably)
• 3.5% mortality
• Revisions for intestinal obstruction
• 6% major complications ( leaks and important intracavitary bleeding)
• malnutrition (my experience in revising Il Int)- sleeve too tight?; interposed ileum problems?
![Page 20: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/20.jpg)
Sleeve gastrectomy in lower BMIs
There were only 3 T2DM pts, with 2 resolutions and 1 improvement, related to weight loss
![Page 21: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/21.jpg)
4
9
8
7
6
5
0 1 2 3 4 5 6 7 8 9
Hb
A1
c (%
)
Time Post Surgery (month)
26
30
29
28
27
0 1 2 3 4 5 6 7 8 9
BM
I (kg
/m2)
Time Post Surgery (month) R Cohen et.al SOARD, 2007
![Page 22: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/22.jpg)
1st Protocol - Original Intact Stomach DJB1st Protocol - Original Intact Stomach DJB
• 46 pts46 pts
- April 2007-March 2008April 2007-March 2008
- 27 men27 men
- Hx of T2DM – 2 to 10 yearsHx of T2DM – 2 to 10 years
- BMI 22-34.9BMI 22-34.9
- Fasting C peptide>1Fasting C peptide>1
- LADA ruled out LADA ruled out ( (negative antibodies)negative antibodies)
![Page 23: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/23.jpg)
• Analysis of Analysis of 46 patients with 46 patients with @ 12 mo @ 12 mo follow-upfollow-up
Surgical treatment of T2DM
![Page 24: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/24.jpg)
Outcomes Classification Outcomes Classification
• ResolutionResolution - - No meds/insulin, HbA1c<7No meds/insulin, HbA1c<7
• ControlControl - - Less meds/no insulin, HbA1c<7Less meds/no insulin, HbA1c<7
• ImprovementImprovement- Less meds/no insulin, HbA1c< - Less meds/no insulin, HbA1c< baselinebaseline
• Non responseNon response - - Same or worst than baselineSame or worst than baseline
![Page 25: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/25.jpg)
Outcomes Classification
Resolution Control ImprovementNo
response
10 cases 4 cases 3 cases 7 cases
Between resolution and Improvement = 70%41 % of pts are OFF MEDS
All insulin users, including non responders are OFF insulin
![Page 26: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/26.jpg)
Delta BMI Delta BMI x A1c and FPGx A1c and FPG
Delta BMI HAS NO IMPACT in the negative variation of A1c AND FPG from preop to 12 months
FPG
No relation between weight
loss/gain and DM resolution
![Page 27: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/27.jpg)
We have learned and moved forward, seeking for better results
• The role of Ghrelin
• The role of the biliary limb lenght
Results w
ere less dramatic
than
those in th
e obese population
![Page 28: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/28.jpg)
GHRELIN
↑ GH
↑ ACTH & Cortisol
↑ Epinephrine
↑ Glucagon?
↓ Adiponectin
↓ Insulin Action
↓ Insulin Secretion
↑ Food Intake
↑ GLUCOSEC
ounter-regulatory
Courtesy of DE Cummings
Ghrelin
is D
iabetogenic
![Page 29: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/29.jpg)
Moving Forward• Increased the biliary limb lenght
Data suggests that altered bile acid levels and composition may contribute to improved glucose and lipid metabolism in patients who have had GB with longer biliary limbs.
ADA,2007
![Page 30: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/30.jpg)
Sleeved DJB orShort DS
100 cm150 cm
![Page 31: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/31.jpg)
BIG TRIALS• it’s not all about sugar !!!!
2008;358:580-91.2008;358:580-91.
![Page 32: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/32.jpg)
Sleeved DJB orShort DS
• Endpoints in 24 mo
• A) Primary
• Glycemic control - fasting and post prandial
• A1c<7
• B) Secondary
• Blood pressure
• Lipids
• Carothideal Inthima Thickness(CIT)
![Page 33: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/33.jpg)
2nd Protocol - Sleeved DJB orShort DS
• May 2008 - Jul 2009• 78 operated cases
• Mean BMI = 28.6 ( 25.6-30.4)
• Mean time of Hx of T2DM - 13.3 y( 4-20 y)
• Mean preop A1c= 8.2+- 0.9
• 46 insulin users ( 59%)
• Ruled out LADA ( negative GAD/ICA)
• Fasting C peptide over 1, with corrected fasting glycemia below 120 mg/dl
• Increase of C peptide after a mixed meal challenge
![Page 34: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/34.jpg)
Sleeved DJB orShort DS
• RESULTS• First 30 pts @ 12mo Follow up
• TBWL 9.7% +- 2.6%
• 22 insulin users
Follow-up
Mean A1c
Insulin Unchanged Control,A1c<7
Less medsResolution No meds,A1c<7
12 mo 6.3+-0.4* NONE 3%( 1 pt) 24%(10 pts) 63%(19 pts)
* 11 ( 37%) pts with A1c less than 6
97% between Control &Resolution
![Page 35: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/35.jpg)
Is there weight loss relation to T2DM resolution?
• Although there is some weight loss, there is no direct cause-effect relation !
![Page 36: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/36.jpg)
Why the more WL, worst outcome?Can anybody tell me why?
Delta BMI
A1c<7, NO MEDS
Change in body composition?
![Page 37: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/37.jpg)
• Hb A1c preop to 12 months - * p<0,05
8..9+-0.9
7.1+-0.46.9+-0.6
6.3+-0.4*
![Page 38: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/38.jpg)
FPG preop to 12 months - * p<0,05
176+-19
123+-9101 +-13*
142+-23
![Page 39: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/39.jpg)
120 min Mixed meal challenge preop to 12 months - * p<0,05
242+-23
176+-11
140+-13
161+-14
Preop 3 mo 6 mo 12 mo
![Page 40: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/40.jpg)
CIT
• n= 30, in mm, * p<0.05
preop 3 mo 12 mo
0,71±0,16 0,69±0,11 0,60±0,14*
*p<0.05 vs. preop
![Page 41: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/41.jpg)
BP(mmHg)n= 30, *p<0,05 PAD, preop- 12 mo
preop 6 mo 12 mo
PAS 131,1±14,5 123±11,9
120 ±13,8
PAD 88,7±7.4 80±12,5 71 ±12,7*
![Page 42: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/42.jpg)
Lipid Profile
Preop 6 mo 12 mo
HDL 41 ±9,5 44 ±6,7 48,7 ±9,8
LDL 181 ±23,7 127±13,5 101 ±12,7*
Tryglycerides 337 ±54,3 210 ±31,9 111 ±14,3*
* p<0.05
![Page 43: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/43.jpg)
Short DS and low BMI T2DMPredictors of Success(A1c<7)
• There is NO significance, comparing preop to 3,6, 9 & 12 mo ( **p<0.05)
• Gender
• Time of Hx of T2DM ( 2- 20 years)
• Previous use of insulin
• Weight loss
• Homa IR decrease
• Homa B increase
• Preop fasting and stimulated C peptide
• ** p value of Chi-Square test, Exact Fisher test or Mann-Whitney test
![Page 44: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/44.jpg)
Delta WC x Success
• If pts lost > 7% of WC @ 6 mo they tend to succeed (P=0,05, Non parametric Mann-Whitney test)
![Page 45: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/45.jpg)
GI Surgery for T2DM
• Sleeved DJB /Short DS is more effective that “Classic DJB”
• The only predictor is the loss of more than 7% of WC until the 6th month
![Page 46: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/46.jpg)
• T2DM history and previous use of insulin(after proper screening)has no effect on success
• No straight relation between WL and success
• Why the more WL, less chance for success???? Change of paradigm !
![Page 47: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/47.jpg)
DJB-literature
![Page 48: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/48.jpg)
DJB-literature
Remission Improvement remission and improved
LRYGB 100% 100%
LSG 67% 33% 100%
LAGB 50% 25% 75%
LSG+DJB 93% 7% 100%
![Page 49: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/49.jpg)
DJB-literature
Modest decrease in BMI, withdecrease in A1c @ 6 mo
![Page 50: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/50.jpg)
T2DM surgery in lower BMIs
• BMI 30-35, growing support for surgery in uncontrolled T2DM patients.
• RYGB and BPD seems to have a good role
![Page 51: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/51.jpg)
Treatment AlgorithmWe want to be “an arrow”!!!
BMI > 30
Psychologic stability12 month history of uncontrolled DM/Metabolic Syndrome
Metabolic Surgery
![Page 52: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/52.jpg)
T2DM surgery in lower BMIs
• BMIs below 30 : “Different” patient• Ileal interposition may be a good option, but
carries a high mortality and morbidity rates, as is a complex procedure in a complex patient
• In De Paula’s randomized trial between II+SG versus II+SG+duodenal diversion,bypassing the duodenum improves results!!
• Sleeved duodenal exclusion, seems so far a good procedure, BUT WE NEED MORE DATA!!
![Page 53: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/53.jpg)
T2DM surgery in lower BMIs
• Although we believe that we have several SILENT EVIDENCES, that point us that surgery may benefit T2DM in lower BMIs, we need to start speaking NATIVE CONTEMPORARY DIABETOLESE!
RANDOMIZED CONTROLLED TRIALS!!!
RYGB x Sleeved DJBxBest Med treatment in BMIs 26-35
Work in Progress !!
![Page 54: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/54.jpg)
55
Increased Insulin Resistance
Plasmatic Insulin
Blood sugar
Beta cell failure
Beta cell failure
T2DM symptoms
T2DM symptoms
Insulin Resistance plays a major roleInsulin Resistance plays a major role
Time
APPARENTLY NOT A GOOD CANDIDATE
![Page 55: Surgery for T2DM in BMIs < 35 The Center of Excelence for the Surgical Treatment of Obesity and Metabolic Disorders Hospital Oswaldo Cruz, São Paulo, Brasil](https://reader035.vdocument.in/reader035/viewer/2022062515/56649ceb5503460f949b7a07/html5/thumbnails/55.jpg)
56
Increased Insulin Resistance
Plasmatic Insulin
Blood sugar
Beta cell failure
Beta cell failure
T2DM symptoms
T2DM symptoms
Timing for SurgeryTiming for Surgery
Time
T2DM Surgery